Abstract 592P
Background
Debate surrounds the surgical management of Goblet cell adenocarcinoma (GCA). However, right hemicolectomy (RHC) remains the standard surgical choice for GCA.
Methods
1154 and 867 patients with GCA were extracted from U.S. Surveillance, Epidemiology, and End Results (SEER) and National Cancer Registration and Analysis Service (NCRAS) databases respectively after excluding patients with missing data. Two clusters for each cohort were created using an unsupervised machine learning K-means model (cluster 0, cluster 1). Clustering was evaluated using silhouette (S), Davies Boulden (DB) and Caliniski Harabasz (CH) scores. Clusters were visualised using principal component analysis (PCA) and T-distributed stochastic neighbour embedding (T-SNE). SHapley Additive exPlanations (SHAP) identified clinical features that were the most useful in clustering. Kaplan Meier (KM) statistics and graphs were generated. Decision trees were developed to cluster individual patients in each of the two clusters.
Results
PCA and T-SNE visualisations showed distinct clusters with some overlap in both cohorts. SHAP revealed tumour size and stage as important variables for clustering in SEER, while age and stage were key variables in NCRAS. Clusters description and survival are shown in the table. The two clusters were statistically different in survival based on Cox regression, Log-rank test and KM statistics in both cohorts. Appendectomy and RHC showed similar survival rates across both cohorts and within each cluster of both cohorts. Table: 592P
Characteristics of clusters and 5-year survival rates
Characteristic | Clustrer 0Favourable survival | Cluster 1Unfavourable survival |
Median age, years (SEER) | 58 | 59 |
Male sex, % (SEER) | 48 | 54 |
Localised stage, % (SEER) | 64 | 33 |
Distant stage, % (SEER) | 3 | 19 |
Tumour size, median mm (SEER) | 14 | 50 |
5-year survival, % (95% CI) (SEER) | 85(82-88) | 72(59-72) |
Median age, years (NCRAS) | 48 | 68 |
Male sex, % (NCRAS) | 56 | 43 |
Localised stage, % (NCRAS) | 90 | 81 |
Distant stage, % (NCRAS) | 4 | 9 |
5-year survival, % (95% CI) (NCRAS) | 87(83-91) | 61(57-66) |
Conclusions
After categorising cases into two clusters using unsupervised machine learning, RHC and appendectomy demonstrated comparable survival rates among patients with GCA. Machine learning could facilitate clinicians in exploring the impact of various treatment approaches on survival outcomes.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Hampshire Hospitals NHS Foundation Trust.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
547P - Artificial Intelligence-powered analysis of the tumor immune microenvironment in primary and metastatic colorectal cancer
Presenter: Elio Adib
Session: Poster session 16
548P - Simplified immune score based on CD8+ T-cells at the invasive margin provides comparable prognostic value to immune scores in non-metastatic colorectal cancer
Presenter: Durgesh Wankhede
Session: Poster session 16
549P - Combined morphometric immune signatures define the prognosis of patients with resectable colorectal liver metastases
Presenter: Markus Moehler
Session: Poster session 16
550P - The impact of mismatch repair status on accuracy of clinical staging in upfront resected stage II/III rectal cancer in the Netherlands
Presenter: Renee Lunenberg
Session: Poster session 16
551P - Efficacy prediction of chemoradiotherapy plus anti-PD-1/PD-L1 treatment by magnetic resonance imaging in MSS locally advanced rectal cancer
Presenter: Wentao Tang
Session: Poster session 16
552P - Baseline imaging biomarkers to predict outcomes in locally advanced colon cancer (LACC): Data from the FOxTROT international randomised-controlled trial
Presenter: James Platt
Session: Poster session 16
553P - Association of ctDNA-based MRD detection and MRD clearance with short-term overall survival in patients with resectable colorectal cancer: Updated analysis of CIRCULATE-Japan GALAXY
Presenter: JUN NAGATA
Session: Poster session 16
555P - Association between copy number aberration and ctDNA MRD in colorectal cancer: CIRCULATE-Japan GALAXY
Presenter: TOMOYA HARIMA
Session: Poster session 16